
Nucelion and Pandorum Partner on Ophthalmology Projects
The story in brief
Hyderabad-based Nucelion Therapeutics and Bengaluru’s Pandorum Technologies have partnered to advance two PRIP-backed ophthalmology projects targeting advanced keratopathy and wet AMD. Pandorum’s designer-exosome platform and Nucelion’s GMP expertise will combine for a planned outlay of Rs 16.97 crore, with Rs 8 crore under PRIP. The projects aim to support clinical studies in India and globally.